12:00 AM
Dec 09, 2002
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Transkaryotic Therapies Inc.

(TKTX), Cambridge, Mass.

Business: Gene/Cell therapy, Hematology, Metabolic

SG Cowen analyst Eric Schmidt lowered his rating to "market perform" from "outperform" after...

Read the full 121 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >